Header Logo

Connection

SUSAN BLANEY to Receptor, IGF Type 1

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Receptor, IGF Type 1.
SUSAN BLANEY
Connection Strength
0.423
Receptor, IGF Type 1
  1. Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Mar; 61(3):452-6.
    View in: PubMed
    Score: 0.423
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.